Figure 1.
Bar graph showing the rate of major clinical events in clinical trials comparing 12-month dual antiplatelet strategy (DAPT) vs. a shorter strategy followed by ASA alone.
Bar graph showing the rate of major clinical events in clinical trials comparing 12-month dual antiplatelet strategy (DAPT) vs. a shorter strategy followed by ASA alone.